Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinfeng Zou

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Bioinformatics (Oxford, England)|July 18, 2008
Apparently low reproducibility of true differential expression discoveries in microarray studiesMin Zhang, Chen Yao, Zheng Guo, et al.
Bioinformatics (Oxford, England)|February 24, 2010
Viewing cancer genes from co-evolving gene modulesJing Zhu, Hui Xiao, Xiaopei Shen, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2023
Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patientsKirsty Taylor, Jinfeng Zou, Marcos Magalhaes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 23, 2025
Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancerEmma Collier, Pamela Soberanis Pina, Michelle McMullen, et al.
Cancer Research|June 10, 2026
Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast CancerSasha C Main, Mitchell J Elliott, Althaf Singhawansa, et al.
Haematologica|June 22, 2023
Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemiaTracy Murphy, Jinfeng Zou, Andrea Arruda, et al.
Cell Death and Differentiation|February 26, 2024
Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neckEnrique Sanz-Garcia, Jinfeng Zou, Lisa Avery, et al.
Blood Advances|August 3, 2019
Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AMLTracy Murphy, Jinfeng Zou, Georgina S Daher-Reyes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2023
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical CancerKathy Han, Jinfeng Zou, Zhen Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2021
Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell CarcinomaJustin M Burgener, Jinfeng Zou, Zhen Zhao, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Bioinformatics (Oxford, England)|July 18, 2008
Apparently low reproducibility of true differential expression discoveries in microarray studiesMin Zhang, Chen Yao, Zheng Guo, et al.
Bioinformatics (Oxford, England)|February 24, 2010
Viewing cancer genes from co-evolving gene modulesJing Zhu, Hui Xiao, Xiaopei Shen, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2023
Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patientsKirsty Taylor, Jinfeng Zou, Marcos Magalhaes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 23, 2025
Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancerEmma Collier, Pamela Soberanis Pina, Michelle McMullen, et al.
Cancer Research|June 10, 2026
Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast CancerSasha C Main, Mitchell J Elliott, Althaf Singhawansa, et al.
Haematologica|June 22, 2023
Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemiaTracy Murphy, Jinfeng Zou, Andrea Arruda, et al.
Cell Death and Differentiation|February 26, 2024
Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neckEnrique Sanz-Garcia, Jinfeng Zou, Lisa Avery, et al.
Blood Advances|August 3, 2019
Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AMLTracy Murphy, Jinfeng Zou, Georgina S Daher-Reyes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2023
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical CancerKathy Han, Jinfeng Zou, Zhen Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2021
Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell CarcinomaJustin M Burgener, Jinfeng Zou, Zhen Zhao, et al.
Pageof 5